Good evening, everyone. Welcome to the Stocktwits Top 25 Newsletter for Week 23 in 2021.
The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD), and tracks their performances over time.
Here are your Stocktwits Top 25 Lists for Week 23:
ST Top 25 S&P 500
The ST Top 25 S&P 500 list managed to close green but showed some cracks under the hood. 11 of 25 names closed positive.
Biogen blasted onto the list in epic fashion. The biotech gained 38.62% to become this week’s Top Dawg. Read more below.
$DVN decreased 6.8%, the list’s biggest loser. The energy company is on the Sinners list below.
3 Freshmen made the list. The companies are Biogen, Lumen Technologies, and Fortinet.
The Stocktwits Top 25 S&P 500 Momentum Meter increased 0.77% while the S&P 500 gained 0.42%. The 0.35% differential in favor of the Top 25 shows the top stocks outperformed the full index by a fair amount.
The Big Cap Nasdaq 100
The ST Top 25 N100 racked up the gains again. 19/25 names closed green, the same as last week.
Biogen made the list’s biggest move, scaling from #20 to #1. 👑
$ILMN ascended 8.4% and grabbed the eighteenth spot on the list as a Freshman. Check it out below.
Three Freshmen made the list. The names are Illumina, Liberty Global, and Ulta Beauty.
The ST Top 25 Nasdaq 100 Momentum Meter gained 2.73% in Week 23 while the full Nasdaq 100 climbed 1.65%. The 1.08% differential suggests the top stocks performed much better than the full index.
Small-Cap Russell 2000
The ST Top 25 R2K List was the top-performing list for the fifth straight week.
18 of 25 names closed higher. 9 names gained > 10%.
Prothena Corp exploded 57.4% and burst onto the list ranked #7. The Freshman is featured on the Winners list below.
The ST Top 25 R2K Momentum Meter gained 8.08% while the Russell 2000 index rallied 2.16%. The 5.92% differential shows the top stocks are much stronger than the full index.
ST Top 25 TOP DAWG OF THE WEEK 🐶
The ST Top 25 Top Dawg for Week 23, 2021 is #12 S&P 500 – Biogen Inc.
Biogen blasted 38.6% higher in Week 23 after the company’s Alzheimer’s drug passed US regulation. The biotech stuck out like a sore thumb of strength in mostly red tape.
$BIIB claimed the twelfth spot on the ST Top 25 S&P 500 List as a Freshman.
Aducanumab is the first therapy approved for Alzheimer’s since 2003. The drug will retail for $56,000/yr, we’ll see in a few years if the hefty price tag is worth it.
$BIIB is up 62% YTD.
The Winners 📈
△ #18 N100 – Illumina Inc improved 8.4% in Week 23 and debuted on the ST Top 25 N100 List as a Freshman. It’s ranked #18.
$ILMN is up 22.5% YTD.
△ #7 R2K – Prothena Corp popped 57.4% and closed at three-year highs. The biotech company arrived on the ST Top 25 R2K List as a Freshman, it’s now ranked 7th.
$PRTA soared 30% on Monday after Oppenheimer Increased their price target to $54/share.
The firm said the approval for Aduhelm sets an “important precedent for other anti-Aß antibody candidates”, referring to Prothena’s experimental Alzheimer’s therapy, PRX012 which also targets Aβ (Amyloid beta).
$PRTA is up 275% YTD.
△ #24 R2K – Signet Jewelers spiked 27% after beating earnings and sales expectations. The jewelry store chain also raised FY22 guidance. 💎
Here are the numbers:
EPS: $2.23 vs $1.41 est
Revenue: $1.7B, +106.5% YoY
Here’s the weekly chart:
Virginia Drosos, CEO of Signet Jewelers said:
While the jewelry category is experiencing meaningful growth, we are outpacing market growth and gaining share consistent with our Inspiring Brilliance strategy. Specifically, we are winning in our biggest banners through consumer-inspired differentiation, as evidenced by double-digit revenue growth in both Kay and Zales versus this time two years ago.
$SIG is up 174% YTD.
The Sinners 📉
▼ #12 R2K – SM Energy Company sank 8.5% this week to close at #12 on the ST Top 25 N100 List, six rankings lower than last week.
$SM closed red Monday thru Thursday but bounced back a percent Friday.
On Wednesday, the company announced a $400 million public offering of senior notes due 2028.
$SM is still up 255% YTD.
▼ #3 S&P 500 – Devon Energy Corp dropped 6.8% this week but sat tight in the #3 spot on the ST Top 25 S&P 500 List. $DVN is the biggest loser on the list.
Despite its poor weekly performance, $DVN is still up 80% YTD and well within the top-5.